FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to pediatrics, and can be used in endocrinology, cardiology, obstetrics and gynecology, children's dietetics. Invention relates to method for predicting the growth rate of young children. Essence of this method: by taking a scraping from the mucous membrane of the cheek get the genetic material of the child, DNA is isolated, then genotyping is carried out, and the AA genotype of the rs9939609 FTO gene is detected in young children, including newborns, by real-time PCR. Carriers of this genotype are classified as at risk for accelerated growth and development of the metabolic syndrome and related non-infectious diseases in the future.
EFFECT: proposed method is easy to use, non-invasive, can be used from the moment of birth, highly informative.
1 cl, 1 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF RISK OF DEVELOPING DISEASES ASSOCIATED WITH LEVEL OF IMMUNOGLOBULIN E (IGE) IN HUMAN BLOOD SERUM | 2019 |
|
RU2723390C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPMENT OF HYPERTENSIVE DISEASE FACTORED IN GENETIC AND ENVIRONMENTAL FACTORS | 2018 |
|
RU2678441C1 |
| METHOD FOR PREDICTION OF NEWBORN'S WEIGHT IN PREGNANT WOMEN WITH PRE-ECLAMPSIA AND A FAMILY HISTORY OF PRE-ECLAMPSIA | 2020 |
|
RU2738685C1 |
| METHOD FOR GENOTYPING SINGLE-NUCLEOTIDE VARIANT rs13056243 (C>T) OF HUMAN ZNRF3 GENE BY REAL-TIME POLYMERASE CHAIN REACTION | 2023 |
|
RU2819836C1 |
| METHOD FOR DETECTING PREDISPOSITION TO THE DEVELOPMENT OF METABOLIC SYNDROME IN THE FORM OF OBESITY IN SCHOOLCHILDREN AGED 7-10 YEARS | 2022 |
|
RU2779085C1 |
| METHOD FOR GENOTYPING SINGLE-NUCLEOTIDE VARIANT rs71327329 (A>G) OF THE HUMAN ZNRF3 GENE BY REAL-TIME POLYMERASE CHAIN REACTION | 2023 |
|
RU2821589C1 |
| METHOD FOR PREDICTING DEVELOPMENT OF PERINATAL COMPLICATIONS IN PREGNANT WOMEN AND WOMEN IN LABOR WITH EXCESS WEIGHT OR OBESITY | 2017 |
|
RU2673085C1 |
| METHOD FOR GENOTYPING SINGLE-NUCLEOTIDE VARIANT OF rs5762821 (G>A) OF HUMAN LONG NON-CODING RNA GENE (LNCRNA, ENSEMBL ID: ENSG00000226471) BY REAL-TIME POLYMERASE CHAIN REACTION | 2024 |
|
RU2825465C1 |
| METHOD FOR PREDICTING NEWBORN WEIGHT IN PREGNANT WOMEN WITH PREECLAMPSIA IN COMBINATION WITH FETAL GROWTH RETARDATION SYNDROME | 2020 |
|
RU2741861C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING HYPERTENSIVE DISORDER BASED ON MOLECULAR AND GENETIC DATA | 2018 |
|
RU2679401C1 |
